Heart Failure | FARXIGA® (dapagliflozin) 10 mg tablets | For HCPs If suspected, discontinue FARXIGA, evaluate and treat promptly Withhold FARXIGA, if possible, in temporary clinical situations that could predispose patients to ketoacidosis Resume FARXIGA when the patient is clinically stable and has resumed oral intake
FARXIGA For adults with heart failure, when the heart cannot pump enough blood to the rest of the body, FARXIGA is a prescription medicine approved to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit
What Is Farxiga (Dapagliflozin)? - Heart-Failure. net Farxiga (dapagliflozin) is used for adults with heart failure with reduced ejection fraction It is specifically for those with Class II through IV heart failure, according to the New York Heart Association (NYHA) heart failure guidelines
Effect of Dapagliflozin in Patients with Heart Failure: A Systematic . . . In this study, which was designed to study the effect of dapagliflozin on patients with heart failure, we found a statistically significant association with a reduction in all-cause mortality, cardiovascular mortality, and heart failure-related hospitalization